ENOVIS CORP (ENOV) Fundamental Analysis & Valuation

NYSE:ENOV • US1940141062

Current stock price

22.48 USD
+0.37 (+1.67%)
Last:

This ENOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ENOV Profitability Analysis

1.1 Basic Checks

  • ENOV had positive earnings in the past year.
  • In the past year ENOV had a positive cash flow from operations.
  • ENOV had negative earnings in 4 of the past 5 years.
  • Of the past 5 years ENOV 4 years had a positive operating cash flow.
ENOV Yearly Net Income VS EBIT VS OCF VS FCFENOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

  • With a Return On Assets value of -30.89%, ENOV perfoms like the industry average, outperforming 41.27% of the companies in the same industry.
  • ENOV has a Return On Equity (-79.51%) which is comparable to the rest of the industry.
  • With a decent Return On Invested Capital value of 0.46%, ENOV is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • ENOV had an Average Return On Invested Capital over the past 3 years of 0.36%. This is significantly below the industry average of 9.31%.
  • The last Return On Invested Capital (0.46%) for ENOV is above the 3 year average (0.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROIC 0.46%
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)0.36%
ROIC(5y)N/A
ENOV Yearly ROA, ROE, ROICENOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • The Operating Margin of ENOV (0.84%) is better than 66.67% of its industry peers.
  • ENOV's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 58.16%, ENOV is in line with its industry, outperforming 59.79% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ENOV has grown nicely.
Industry RankSector Rank
OM 0.84%
PM (TTM) N/A
GM 58.16%
OM growth 3YN/A
OM growth 5Y-34.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.43%
GM growth 5Y6.64%
ENOV Yearly Profit, Operating, Gross MarginsENOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ENOV Health Analysis

2.1 Basic Checks

  • ENOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ENOV has been increased compared to 1 year ago.
  • Compared to 5 years ago, ENOV has more shares outstanding
  • The debt/assets ratio for ENOV is higher compared to a year ago.
ENOV Yearly Shares OutstandingENOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENOV Yearly Total Debt VS Total AssetsENOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ENOV has an Altman-Z score of 0.58. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
  • ENOV's Altman-Z score of 0.58 is in line compared to the rest of the industry. ENOV outperforms 47.62% of its industry peers.
  • ENOV has a debt to FCF ratio of 65.11. This is a negative value and a sign of low solvency as ENOV would need 65.11 years to pay back of all of its debts.
  • ENOV has a better Debt to FCF ratio (65.11) than 68.78% of its industry peers.
  • A Debt/Equity ratio of 0.85 indicates that ENOV is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.85, ENOV is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Altman-Z 0.58
ROIC/WACC0.05
WACC8.55%
ENOV Yearly LT Debt VS Equity VS FCFENOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • ENOV has a Current Ratio of 2.02. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ENOV (2.02) is worse than 62.96% of its industry peers.
  • A Quick Ratio of 1.04 indicates that ENOV should not have too much problems paying its short term obligations.
  • ENOV has a worse Quick ratio (1.04) than 76.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.04
ENOV Yearly Current Assets VS Current LiabilitesENOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ENOV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.61% over the past year.
  • The Earnings Per Share has been decreasing by -4.57% on average over the past years.
  • Looking at the last year, ENOV shows a small growth in Revenue. The Revenue has grown by 6.66% in the last year.
  • Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -6.05% on average per year.
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.35% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y9.27%
EPS Next 2Y10.94%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue Next Year3.91%
Revenue Next 2Y4.61%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ENOV Yearly Revenue VS EstimatesENOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ENOV Yearly EPS VS EstimatesENOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. ENOV Valuation Analysis

4.1 Price/Earnings Ratio

  • ENOV is valuated cheaply with a Price/Earnings ratio of 6.81.
  • Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 96.83% of the companies listed in the same industry.
  • ENOV is valuated cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 6.23 indicates a rather cheap valuation of ENOV.
  • Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 98.41% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.67. ENOV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.81
Fwd PE 6.23
ENOV Price Earnings VS Forward Price EarningsENOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 94.71% of the companies listed in the same industry.
  • 72.49% of the companies in the same industry are more expensive than ENOV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 64.62
EV/EBITDA 8.07
ENOV Per share dataENOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y10.94%
EPS Next 3Y11.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ENOV Dividend Analysis

5.1 Amount

  • ENOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENOV Fundamentals: All Metrics, Ratios and Statistics

ENOVIS CORP

NYSE:ENOV (3/25/2026, 3:27:44 PM)

22.48

+0.37 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners117.76%
Inst Owner Change-0.07%
Ins Owners1.22%
Ins Owner Change9.24%
Market Cap1.29B
Revenue(TTM)2.25B
Net Income(TTM)-1.18B
Analysts84.44
Price Target46.36 (106.23%)
Short Float %14.37%
Short Ratio7.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)13.32%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)10.31%
Min EPS beat(4)6.8%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)8.3%
EPS beat(12)12
Avg EPS beat(12)8.63%
EPS beat(16)16
Avg EPS beat(16)9.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.7%
Min Revenue beat(2)-3.32%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)-0.09%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)5
Avg Revenue beat(16)-1.09%
PT rev (1m)0%
PT rev (3m)-5.52%
EPS NQ rev (1m)7.93%
EPS NQ rev (3m)7.92%
EPS NY rev (1m)3.06%
EPS NY rev (3m)2.67%
Revenue NQ rev (1m)-1.84%
Revenue NQ rev (3m)-1.79%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 6.81
Fwd PE 6.23
P/S 0.57
P/FCF 64.62
P/OCF 5.92
P/B 0.86
P/tB N/A
EV/EBITDA 8.07
EPS(TTM)3.3
EY14.68%
EPS(NY)3.61
Fwd EY16.04%
FCF(TTM)0.35
FCFY1.55%
OCF(TTM)3.8
OCFY16.88%
SpS39.27
BVpS26.02
TBVpS-8.13
PEG (NY)0.73
PEG (5Y)N/A
Graham Number43.95
Profitability
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROCE 0.58%
ROIC 0.46%
ROICexc 0.46%
ROICexgc 1.19%
OM 0.84%
PM (TTM) N/A
GM 58.16%
FCFM 0.89%
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)0.36%
ROIC(5y)N/A
ROICexc(3y)0.36%
ROICexc(5y)N/A
ROICexgc(3y)1.26%
ROICexgc(5y)N/A
ROCE(3y)0.45%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-36.37%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.16%
OM growth 3YN/A
OM growth 5Y-34.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.43%
GM growth 5Y6.64%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Debt/EBITDA 4.03
Cap/Depr 67.05%
Cap/Sales 8.78%
Interest Coverage 0.69
Cash Conversion 69.38%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.04
Altman-Z 0.58
F-Score4
WACC8.55%
ROIC/WACC0.05
Cap/Depr(3y)62.27%
Cap/Depr(5y)54.89%
Cap/Sales(3y)8.17%
Cap/Sales(5y)7.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
EPS Next Y9.27%
EPS Next 2Y10.94%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%
Revenue Next Year3.91%
Revenue Next 2Y4.61%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y53.77%
EBIT growth 3YN/A
EBIT growth 5Y-38.41%
EBIT Next Year53.87%
EBIT Next 3Y21.57%
EBIT Next 5YN/A
FCF growth 1Y129.63%
FCF growth 3YN/A
FCF growth 5Y-36.11%
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5Y-6.37%

ENOVIS CORP / ENOV Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.


What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.


Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.


What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 9.27% in the next year.